GLP-2 TRZ is a synthetic dual-agonist peptide targeting both GLP-1 and GIP receptors, produced for controlled metabolic signaling research.

What research models use GLP-2 TRZ?

GLP-2 TRZ is examined in preclinical models studying incretin receptor co-activation, dual-pathway metabolic signaling, and receptor selectivity profiles.

How is product quality verified?

Every batch undergoes 8 rounds of independent analytical testing: HPLC purity analysis, mass spectrometry identity confirmation, net peptide content, endotoxin screening, sterility verification, heavy metals, trace contaminant analysis, and multi-vial conformity. Full Certificates of Analysis documenting all results are available for each production lot.

GLP-2 TRZ: Research Peptide Details

Supplied as a 10mg, 20mg, 40mg, and 60mg lyophilized powder in a 3ml vial, GLP-2 TRZ is intended exclusively for laboratory research use only in controlled experimental settings and is not for human consumption.